{"id":1552,"date":"2018-12-17T09:12:12","date_gmt":"2018-12-17T08:12:12","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1552"},"modified":"2018-12-17T09:12:12","modified_gmt":"2018-12-17T08:12:12","slug":"nanexa-ingar-avtal-med-varldsledande-animal-health-bolag","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/","title":{"rendered":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag"},"content":{"rendered":"<p><strong>Pressmeddelande <\/strong><\/p>\n<p>Uppsala 2018-12-17<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag<\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>Nanexa skrev sent fredag kv\u00e4ll ett kommersiellt utv\u00e4rderingsavtal, ett s\u00e5 kallat \u201dMaterial transfer and feasibility study agreement\u201d, med ett v\u00e4rldsledande globalt animal health-bolag.<\/p>\n<p>Bolaget som har sitt huvudkontor i USA kommer inom ramen f\u00f6r avtalet utv\u00e4rdera PharmaShell<sup>\u00ae<\/sup>f\u00f6r en specifik kombinationsprodukt. Det \u00e4r PharmaShells<sup>\u00ae<\/sup>egenskaper som g\u00f6r det m\u00f6jligt att skapa riktigt l\u00e5nga dep\u00e5produkter som efterfr\u00e5gats av det amerikanska bolaget.<\/p>\n<p>Avtalet inneb\u00e4r att Nanexa ska bel\u00e4gga bolagets aktiva substanser med PharmaShell<sup>\u00ae <\/sup>och att de i sin tur utv\u00e4rderar effekten av detta i relevanta modeller f\u00f6r deras t\u00e4nkta produktutveckling. Produkten som de siktar p\u00e5 att utveckla med PharmaShell<sup>\u00ae<\/sup>\u00e4r f\u00f6r en betydande indikation och planeras att anv\u00e4ndas f\u00f6r flera djurslag. Den globala marknaden f\u00f6r animal health v\u00e4rderas till 42.2 miljarder USD med en \u00e5rlig tillv\u00e4xt p\u00e5 5,5% enligt Grand View Research, June 2018.<\/p>\n<p>Animal-health bolaget st\u00e5r f\u00f6r alla kostnader f\u00f6r utv\u00e4rdering och Nanexa erh\u00e5ller en avtalad mindre ers\u00e4ttning vid leverans av belagt material.<\/p>\n<p>&nbsp;<\/p>\n<p><em>F\u00f6retagets VD David Westberg kommenterar:<\/em><\/p>\n<p><em>\u201dJag \u00e4r mycket n\u00f6jd \u00f6ver att vi nu har tecknat ett kommersiellt avtal med ett stort globalt f\u00f6retag inom den attraktiva animal health-branschen. Det \u00e4r ett stort steg i helt r\u00e4tt riktning f\u00f6r Nanexa.\u201d<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>F\u00f6r mer information kontakta:<\/p>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n<p>Telefon: 0709 -42 83 03<\/p>\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\n<p>www.nanexa.com<\/p>\n<p>&nbsp;<\/p>\n<p><em>Denna information \u00e4r s\u00e5dan information som Nanexa AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 17 december, 2018.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande <\/p>\n<p>Uppsala 2018-12-17<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag<\/p>\n<p>\u00a0<\/p>\n<p>Nanexa skrev sent fredag kv\u00e4ll ett kommersiellt utv\u00e4rderingsavtal,<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1552","post","type-post","status-publish","format-standard","hentry","category-pressmeddelanden"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande Uppsala 2018-12-17 &nbsp; Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag \u00a0 Nanexa skrev sent fredag kv\u00e4ll ett kommersiellt utv\u00e4rderingsavtal,L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-17T08:12:12+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag\",\"datePublished\":\"2018-12-17T08:12:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/\"},\"wordCount\":355,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/\",\"name\":\"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-12-17T08:12:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB","og_description":"Pressmeddelande Uppsala 2018-12-17 &nbsp; Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag \u00a0 Nanexa skrev sent fredag kv\u00e4ll ett kommersiellt utv\u00e4rderingsavtal,L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/","og_site_name":"Nanexa AB","article_published_time":"2018-12-17T08:12:12+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag","datePublished":"2018-12-17T08:12:12+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/"},"wordCount":355,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/","url":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/","name":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-12-17T08:12:12+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-ingar-avtal-med-varldsledande-animal-health-bolag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa ing\u00e5r avtal med v\u00e4rldsledande animal health-bolag"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1552"}],"version-history":[{"count":2,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1552\/revisions"}],"predecessor-version":[{"id":1554,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1552\/revisions\/1554"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}